drugset / Trial / NCT02322619
Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, oral bioequivalence study in human subjects under fasting conditions.
Timeline
- Start
- 2012-11
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.